Literature DB >> 2546445

Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators.

U C Garg1, A Hassid.   

Abstract

Recent studies indicate that endothelium-derived relaxing factor (EDRF) may be identical with nitric oxide (NO). The purpose of this study was to investigate the antimitogenic effect of NO-generating drugs in cultured mesangial cells. S-nitroso-N-acetylpenicillamine, sodium nitroprusside, and isosorbide dinitrate, which generate NO, dose dependently inhibited serum-stimulated DNA synthesis. All three drugs also inhibited the rate of cell proliferation, whereas sodium nitroprusside and S-nitroso-N-acetylpenicillamine decreased cell density at confluence. The antimitogenic activity of S-nitroso-N-acetylpenicillamine was labile in culture medium and could be inhibited by hemoglobin, supporting the view that NO, in free or bound form, was the ultimate effector. All three vasodilators increased cellular guanosine 3',5'-cyclic monophosphate (cGMP) levels dose dependently; moreover, 8-bromo-cGMP mimicked the effects of the NO-generating drugs, suggesting that cGMP may be an intracellular mediator of antimitogenesis. The growth-inhibitory effect of S-nitroso-N-acetylpenicillamine was reversible and was not due to cell toxicity as shown by several criteria of cell viability. The results raise the possibility that EDRF/NO may be a modulator of mesangial cell growth in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546445     DOI: 10.1152/ajprenal.1989.257.1.F60

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  34 in total

1.  Nitric oxide inhibits irreversibly P815 cell proliferation: involvement of potassium channels.

Authors:  R S A Costa; J Assreuy
Journal:  Cell Prolif       Date:  2002-12       Impact factor: 6.831

2.  Basal and stimulated nitric oxide in control of kidney function in the aging rat.

Authors:  C Hill; A M Lateef; K Engels; L Samsell; C Baylis
Journal:  Am J Physiol       Date:  1997-06

3.  Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.

Authors:  Ying Zhu; Jian Yao; Yiman Meng; Ayumi Kasai; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Takashi Miida; Masayuki Takeda; Masahiko Okada; Masanori Kitamura
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

4.  Tissue injury caused by deposition of immune complexes is L-arginine dependent.

Authors:  M S Mulligan; J M Hevel; M A Marletta; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

5.  Nitric oxide (NO) donor 3-morpholinosydnonimine antagonizes cyclosporin A-induced contraction in two in vitro glomerular models.

Authors:  M Potier; J Winicki; J Cambar
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

6.  Kidney is in trouble with mediators.

Authors:  Ayse Balat
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

7.  Nitric oxide is involved in the regulation of angiogenesis.

Authors:  E Pipili-Synetos; E Sakkoula; M E Maragoudakis
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  Cell density modulates the decrease of cytosolic free Ca2+ induced by atrial natriuretic hormone, S-nitroso-N-acetylpenicillamine and 8-bromo cyclic GMP in cultured rat mesangial cells.

Authors:  F Lermioglu; J Goyal; A Hassid
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

9.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.

Authors:  M Hogan; A Cerami; R Bucala
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.